India Exchange Filings

European Launch of Biosimilar Ranibizumab

Lupin Ltd partner Sandoz launches biosimilar ranibizumab Ranluspec across Europe, excluding Germany

  • Launch follows European Commission approval of vial and pre-filled syringe presentations.
  • Ranluspec is indicated for several retinal and choroidal vascular conditions.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.